MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,610,537 | -0.2% | 2,023,672 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $2,616,776 | +63.6% | 1,982,406 | -12.4% | 0.00% | – |
| Q1 2023 | $1,599,563 | -7.1% | 2,262,785 | -1.4% | 0.00% | – |
| Q4 2022 | $1,721,075 | +181.7% | 2,294,766 | +223.6% | 0.00% | – |
| Q3 2022 | $611,000 | -24.0% | 709,126 | -1.2% | 0.00% | – |
| Q2 2022 | $804,000 | +0.4% | 717,455 | +0.3% | 0.00% | – |
| Q1 2022 | $801,000 | -29.7% | 715,185 | +0.4% | 0.00% | – |
| Q4 2021 | $1,140,000 | – | 712,363 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |